Get the latest NAV of HDFC Pharma and Healthcare Fund. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹17.89
1D
NAV as on 09 Mar 2026
27.82%/per year
Since Inception
▲▼
12499 people have invested ₹ 2.3Cr in HDFC Pharma and Healthcare Fund in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (09-Mar-26)
The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.
Powered by IND quant engine
IND ranking is not available for this fund.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (14-Feb-26)
Fund Distribution
as on (14-Feb-26)
See fund sector allocation details as on (14-Feb-26)
Sector Allocation
Top 2 Sectors in January were Health, Basic Materials
Health
96%
Basic Materials
4%
Health
97%
Basic Materials
3%
as on (28-Feb-26)
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
| Expense ratio | 0.95% |
Benchmark | BSE Healthcare TR INR |
| AUM | ₹1876 Cr |
| Inception Date | 4 October, 2023 |
| Min Lumpsum/SIP | ₹100/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 38.18% |
| Risk | Very High Risk |
HDFC Pharma and Healthcare Fund is an equity fund. This fund was started on 4 October, 2023. The fund is managed by Dhruv Muchhal, Nikhil Mathur. The fund could potentially beat inflation in the long-run.
HDFC Pharma and Healthcare Fund has given a CAGR return of 27.82% since inception. Over the last 1 year the fund has given a CAGR return of 16.75%.
HDFC Pharma and Healthcare Fund has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Alkem Laboratories Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. HDFC Pharma and Healthcare Fund has no lock in period.
Fund Manager of HDFC Pharma and Healthcare Fund, since 4 October 2023
Fund Manager of HDFC Pharma and Healthcare Fund, since 4 October 2023